Exponent (EXPO) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
7 Nov, 2025Executive summary
Achieved double-digit net revenue growth in Q3 2025, driven by strong demand for dispute-related, risk management, and regulatory consulting services across energy, transportation, life sciences, construction, and utilities sectors.
Proactive and reactive engagements saw robust activity, with notable contributions from utilities, chemicals, and improving trends in consumer electronics.
AI and transformative technologies are increasingly integrated into client projects, especially in safety-critical systems, positioning the company as a leader in complex technical challenges.
Over 50 years of multidisciplinary consulting expertise, with 900+ consulting staff and 650+ doctoral-level professionals as of 12/31/24.
Strong reputation for rigorous, objective technical analysis and a diversified portfolio across high-risk, high-exposure global challenges.
Financial highlights
Q3 2025 total revenues rose 8% year-over-year to $147.1M; revenues before reimbursements up 10% to $137.1M.
Q3 2025 net income increased to $28.0M ($0.55 per diluted share) from $26.0M ($0.50) in Q3 2024.
Q3 2025 EBITDA grew to $38.8M (28.3% margin), compared to $35.8M (28.6%) last year.
Billable hours up 4% to 376,000; technical FTEs up 3% to 976.
Cash and cash equivalents at quarter-end: $207.4M, down from $258.9M at the start of the year.
Outlook and guidance
Q4 2025 net revenue expected to grow low to mid-single digits; EBITDA margin guidance 26%-27%.
Full-year 2025 net revenue to grow low single digits; EBITDA margin raised to 27.4%-27.65%.
Q4 utilization expected at 68%-70% (seasonally lower); full-year utilization at 72.5%.
Realized rate increase for 2025 forecast at 4%-5%.
Company maintains revenue guidance and raises margin guidance for the full year.
Latest events from Exponent
- Strong Q4 and FY2025 results, with high-single-digit growth and stable margins expected in 2026.EXPO
Q4 20255 Feb 2026 - Q2 2024 net income up 14% on flat revenues, with raised guidance and strong sector demand.EXPO
Q2 20242 Feb 2026 - Q3 net income up 6% to $26M, margin guidance raised, and $0.28 dividend declared.EXPO
Q3 202418 Jan 2026 - Q4 and FY24 results exceeded expectations; 2025 growth to be modest amid headcount recovery.EXPO
Q4 202425 Dec 2025 - Flat Q1 revenue, lower net income, and stable 2025 outlook with rising headcount.EXPO
Q1 202523 Dec 2025 - Shareholders will vote on director elections, auditor ratification, and executive pay, all recommended for approval.EXPO
Proxy Filing1 Dec 2025 - Q2 2025 revenues up 1%, lower margins, strong dispute-related growth, positive outlook.EXPO
Q2 202516 Nov 2025